Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 26, 2021

View Archived Issues

CT-859 improves survival in a murine NASH model

New animal model reveals effects of TM6SF2 gene variant on VLDL lipidation

Preclinical data presented for recombinant myxoma virus MC509-N1 in cancer

Adenosine A2A receptor antagonists identified at Adorx Therapeutics

New MAP4K1 inhibitors synthesized at Pfizer

Takeda Pharmaceutical presents new ABCC2 inhibitors

Merck, Cancer Research Technology divulge YAP1/TEAD interaction inhibitors

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Study reports tumors change as patients age

Glycotope's tumor-targeting IL-15-based immunocytokine shows efficacy in preclinical models

Repurposing of riluzole for the treatment of Niemann-Pick disease, type C1

Attenuated measles vaccine expressing the S antigen protects mice and hamsters from SARS-CoV-2

SHP-1 abundance determines the responsiveness of an individual NK cell

Compounds targeting NPC1 protein show promising antiviral activity against SARS-CoV-2

Osteoclasts modified with tetracycline show efficacy in models of heterotopic ossification

ALD-2510 selectively depletes tumor-infiltrating Tregs for activity in vivo

Polycystic ovary syndrome murine model reveals CYP17 involvement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...